the Correlation Between Erythrocyte Index Levels with The Anemia Morphology in Leprosy Patients Before Therapy: A Secondary Data Research

Marrietta Sugiarti Sadeli; Luh Made Mas Rusyati; Ni Luh Putu Ratih Vibriyanti Karna

doi:10.37287/ijghr.v6i6.5826

Marrietta Sugiarti Sadeli Universitas Udayana
Luh Made Mas Rusyati Universitas Udayana
Ni Luh Putu Ratih Vibriyanti Karna Universitas Udayana

DOI: https://doi.org/10.37287/ijghr.v6i6.5826

Keywords: anemia morphology, erythrocyte index, leprosy

Abstract

Leprosy is a chronic inflammatory disease caused by Mycobacterium leprae. Chronic infection can cause anemia of chronic disease which is characterized by normochromic normocytic morphology. This study was conducted to assess the relationship between erythrocyte index levels (MCV, MCH, and MCHC) with the morphology of anemia that occurs in leprosy patients before treatment. A cross-sectional study using secondary data from medical records and management information system applications at Sanglah Hospital. The variables of this study were age, sex, hemoglobin levels, and erythrocyte index levels (MCV, MCH, and MCHC). Data were collected after permission was granted and ethical clearance was completed. Of the 156 study samples, 106 patients were diagnosed with leprosy who had not received therapy and 50 patients were not leprosy. The mean age of the patients was 39.15 ± 12.218 years and male patients were more common than female patients. There was a positive correlation between anemia, normal erythrocyte index levels, and the leprosy group. Following are the p-values, prevalence ratios, and confidence intervals; anemia [p= 0.017; PR(95% CI)= 1,458(1.034-2.056)], MCV, MCH, and MCHC [p= 0.020; PR(95% CI)= 1,268(1.010-1.591); p= 0.015; PR(95% CI)= 1,293(1,021-1,639); p= 0.009; PR(95% CI)= 1,297(1,036-1,624)]. The results of the analysis were statistically significant and clinically important. Leprosy patients had anemia before therapy with normochromic normocytic anemia morphology in accordance with anemia of chronic disease.

References

Agura, L. S. (2024). Blood Cellular Hematological Changes in Patients with Visceral Leishmaniasis Attending Kimalel Sub-County Hospital, Baringo County, Kenya. JKUAT-COHES.

Balgomera, M. N. B., Venida-Tablizo, A. A., Chavez, C. P., Abad-Venida, M. L., Protacio, F. V. M., & Santos, M. P. (2024). Knowledge, attitudes, and practices on leprosy among dermatology residents in the Philippines: a cross-sectional study. Hansenologia Internationalis: Hanseníase e Outras Doenças Infecciosas, 49, e40301–e40301.

Chaparro, C. M., & Suchdev, P. S. (2019). Anemia epidemiology, pathophysiology, and etiology in low‐and middle‐income countries. Annals of the New York Academy of Sciences, 1450(1), 15–31.

Chase, M. L., Drews, R., Zumberg, M. S., Ellis, L. R., Reid, E. G., Gerds, A. T., Lee, A. I., Hobbs, G. S., Berry, J., & Freed, J. A. (2023). Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency. Blood Advances, 7(13), 3244–3252.

Chuang, Y., Zargoush, M., Ghazalbash, S., Samiedaluie, S., Kuluski, K., & Guilcher, S. (2023). From prediction to decision: Optimizing long‐term care placements among older delayed discharge patients. Production and Operations Management, 32(4), 1041–1058.

De Oliveira, A. L. G., Chaves, A. T., Cardoso, M. S., Pinheiro, G. R. G., de Jesus, A. C. P., de Faria Grossi, M. A., Lyon, S., Bueno, L. L., da Costa Rocha, M. O., & Fujiwara, R. T. (2020). Hypovitaminosis D and reduced cathelicidin are strongly correlated during the multidrug therapy against leprosy. Microbial Pathogenesis, 147, 104373.

Grossi, M., Parolin, C., Vitali, B., & Riccò, B. (2019). Electrical Impedance Spectroscopy (EIS) characterization of saline solutions with a low-cost portable measurement system. Engineering Science and Technology, an International Journal, 22(1), 102–108.

Liu, Y., Yu, M., Ning, Y., & Wang, H. (2018). A study on gender differences in newly detected leprosy cases in Sichuan, China, 2000–2015. International Journal of Dermatology, 57(12), 1492–1499.

Nery, J. S., Ramond, A., Pescarini, J. M., Alves, A., Strina, A., Ichihara, M. Y., Penna, M. L. F., Smeeth, L., Rodrigues, L. C., & Barreto, M. L. (2019). Socioeconomic determinants of leprosy new case detection in the 100 Million Brazilian Cohort: a population-based linkage study. The Lancet Global Health, 7(9), e1226–e1236.

Padmawijaya, G., Jalal, A. R., & Mustari, Z. (2022). Severe anemia on the treatment of a Lepra patient with a history of long-term steroid consumption suspect of Cushing syndrome. Qanun Medika-Medical Journal Faculty of Medicine Muhammadiyah Surabaya, 6(2).

Pepito, V. C. F., Loreche, A. M., Samontina, R. E. D., Abdon, S. J. A., Fuentes, D. N. L., & Saniel, O. P. (2023). Factors affecting treatment adherence among leprosy patients: Perceptions of healthcare providers. Heliyon, 9(7).

Reilley-Luther, J., Cline, A., Zimmerly, A., Azinge, S., & Moy, J. (2020). Representation of Fitzpatrick skin type in dermatology textbooks compared with national percentiles. Dermatology Online Journal, 26(12).

Salokhiddinovna, X. Y. (2023). Anemia of Chronic Diseases. Research Journal of Trauma and Disability Studies, 2(12), 364–372.

Setyawati, N. K., Rusyati, L. M. M., Indira, I. G. A. A. E., Praharsini, I. G. A. A., Darmaputra, I. G. N., & Karmila, I. G. A. A. D. (2024). Anemia on Chronic Disease in Leprosy Before and After Completing Multi Drug Therapy. Eduvest-Journal of Universal Studies, 4(9), 8409–8417.

Simbauranga, R. H., Kamugisha, E., Hokororo, A., Kidenya, B. R., & Makani, J. (2015). Prevalence and factors associated with severe anaemia amongst under-five children hospitalized at Bugando Medical Centre, Mwanza, Tanzania. BMC Hematology, 15, 1–9.